path | Ricerc@Sapienza

Efficacy and safety of IVIG in CIDP. Combined data of the PRIMA and PATH studies

Intravenous immunoglobulin (IVIG) is a potential therapy for chronic inflammatory demyelinating polyneuropathy (CIDP).